首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1451707

2024-2032 年按類型、技術、形式、應用和地區分類的核苷酸市場報告

Nucleotides Market Report by Type, Technology, Form, Application, and Region 2024-2032

出版日期: 2024年03月02日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年，全球核苷酸市場規模達到7.184億美元。展望未來， IMARC Group預計到2032年市場規模將達到12.518億美元，2024-2032年複合年成長率（CAGR）為6.2%。

核苷酸是核酸的基本組成部分，例如核糖核酸（RNA）和脫氧核糖核酸（DNA）。它們增強各種代謝過程和細胞中合成的蛋白質結構的形成。它們與酵素作用，加速體內的生化反應。它們也透過與嘌呤能受體的相互作用來幫助大分子的生物合成和細胞訊號傳導。此外，核苷酸也有助於體內編碼、傳遞和表達遺傳訊息。由於核苷酸對皰疹病毒具有高度的效力和選擇性，因此在多種藥物中用作抗病毒或抗癌劑。

核苷酸市場趨勢：

目前，全球範圍內優格、煉乳和奶粉等乳製品中核苷酸補充劑的使用量有所增加。這一點，加上這些粉末狀液體補充劑的供應量不斷增加，是推動市場發展的關鍵因素之一。除此之外，營養保健品中擴大使用核苷酸來治療營養不良、壓力和高血壓等疾病，也促進了市場的成長。此外，核苷酸在診斷研究中的應用不斷增加，以診斷各種病毒性疾病和癌症類型的存在，正在推動市場的成長。此外，為了維持牲畜的新陳代謝率，動物飼料中對核苷酸的需求也在增加。再加上大眾對動物疾病有害影響的認知不斷增強，正在對市場產生正面影響。除此之外，對核苷酸的需求不斷增加，以促進腸上皮細胞的恢復，有助於增強免疫系統，這提供了積極的市場前景。此外，核糖核苷酸在嬰兒食品配方中的使用不斷增加也促進了市場的成長。

本報告回答的關鍵問題：

迄今為止，全球核苷酸市場表現如何，未來幾年將如何表現？
COVID-19 對全球核苷酸市場有何影響？
主要區域市場有哪些？
依類型分類市場是怎麼樣的？
基於技術的市場區隔是什麼？
市場的細分是基於什麼形式？
基於應用程式的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球核苷酸市場的結構如何？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- CJ CheilJedang Corporation
- Exotic Biosolutions
- F. Hoffmann-La Roche AG
- Jena Bioscience GmbH
- Koninklijke DSM NV
- Lallemand Inc.
- Meridian Bioscience Inc.
- Nanjing Biotogether Co. Ltd.
- Ohly GmbH (Associated British Foods plc)
- Promega Corporation
- Starlake Bioscience Co. Inc.
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112024A6472

The global nucleotides market size reached US$ 718.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,251.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032.

Nucleotides are the basic building block of nucleic acids, such as ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). They enhance various metabolic processes and the formation of the structure of proteins synthesized in the cell. They act with enzymes to speed up biochemical reactions in the body. They also aid in the biosynthesis of macromolecules and cell signaling through interaction with purinergic receptors. In addition, nucleotides assist in encoding, transmitting, and expressing genetic information in the body. As they provide a high degree of potency and selectivity against the herpes group of viruses, nucleotides are used as antiviral or anticancer agents in several medicines.

Nucleotides Market Trends:

At present, there is a rise in the utilization of nucleotide supplements in dairy products, such as yogurt and condensed and powdered milk, across the globe. This, along with the growing availability of these supplements in the form of powdered fluids, represents one of the key factors driving the market. Besides this, the increasing employment of nucleotides in nutraceuticals to treat conditions, such as poor nutrition, stress, and hypertension, is contributing to the growth of the market. In addition, the rising application of nucleotides in diagnostic research to diagnose the presence of various viral diseases and types of cancer is propelling the growth of the market. Moreover, there is an increase in the demand for nucleotides in animal feed to maintain metabolism rates in livestock. This, coupled with the growing awareness among the masses about the harmful impacts of animal diseases, is positively influencing the market. Apart from this, the escalating demand for nucleotides to enhance the recovery of intestinal epithelial cells, which helps boost the immunity system, is offering a positive market outlook. Additionally, the increasing usage of ribonucleotides in infant food formulations is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleotides market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, form and application.

Breakup by Type:

Food Grade

Lab Grade

Industry Grade

Others

Breakup by Technology:

TaqMan Allelic Discrimination

Gene Chips and Microarrays

SNP by Pyrosequencing

Others

Breakup by Form:

Liquid

Powder

Breakup by Application:

Pharmaceutical

Food and Animal Feed Additives

Drug Discovery

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

How has the global nucleotides market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global nucleotides market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the form?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global nucleotides market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Nucleotides Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Food Grade
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Lab Grade
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Industry Grade
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Technology

7.1 TaqMan Allelic Discrimination
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Gene Chips and Microarrays
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 SNP by Pyrosequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Form

8.1 Liquid
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Powder
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Application

9.1 Pharmaceutical
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Food and Animal Feed Additives
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Drug Discovery
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 CJ CheilJedang Corporation
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
- 15.3.2 Exotic Biosolutions
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 F. Hoffmann-La Roche AG
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
- 15.3.4 Jena Bioscience GmbH
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Koninklijke DSM N.V.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Lallemand Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Meridian Bioscience Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Nanjing Biotogether Co. Ltd.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Ohly GmbH (Associated British Foods plc)
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Promega Corporation
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Starlake Bioscience Co. Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
- 15.3.12 Thermo Fisher Scientific Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

簡介目錄圖表

List of Figures

Figure 1: Global: Nucleotides Market: Major Drivers and Challenges
Figure 2: Global: Nucleotides Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Nucleotides Market: Breakup by Type (in %), 2023
Figure 5: Global: Nucleotides Market: Breakup by Technology (in %), 2023
Figure 6: Global: Nucleotides Market: Breakup by Form (in %), 2023
Figure 7: Global: Nucleotides Market: Breakup by Application (in %), 2023
Figure 8: Global: Nucleotides Market: Breakup by Region (in %), 2023
Figure 9: Global: Nucleotides (Food Grade) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Nucleotides (Food Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Nucleotides (Lab Grade) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Nucleotides (Lab Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Nucleotides (Industry Grade) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Nucleotides (Industry Grade) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Nucleotides (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Nucleotides (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Nucleotides (TaqMan Allelic Discrimination) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Nucleotides (TaqMan Allelic Discrimination) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Nucleotides (Gene Chips and Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Nucleotides (Gene Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Nucleotides (SNP by Pyrosequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Nucleotides (SNP by Pyrosequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Nucleotides (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Nucleotides (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Nucleotides (Liquid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Nucleotides (Liquid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Nucleotides (Powder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Nucleotides (Powder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Nucleotides (Pharmaceutical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Nucleotides (Pharmaceutical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Nucleotides (Food and Animal Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Nucleotides (Food and Animal Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Nucleotides (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Nucleotides (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Nucleotides (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Nucleotides (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Nucleotides Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Nucleotides Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Nucleotides Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Nucleotides Industry: SWOT Analysis
Figure 87: Global: Nucleotides Industry: Value Chain Analysis
Figure 88: Global: Nucleotides Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Nucleotides Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Nucleotides Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Nucleotides Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Nucleotides Market Forecast: Breakup by Form (in Million US$), 2024-2032
Table 5: Global: Nucleotides Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Nucleotides Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Nucleotides Market: Competitive Structure
Table 8: Global: Nucleotides Market: Key Players

02-2729-4219

+886-2-2729-4219